Quality Chemical Industries Limited (UGSE:QCIL)

Uganda flag Uganda · Delayed Price · Currency is UGX
110.00
0.00 (0.00%)
At close: Aug 15, 2025
96.43%
Market Cap 401.71B
Revenue (ttm) 267.13B
Net Income (ttm) 40.65B
Shares Out 3.65B
EPS (ttm) 11.13
PE Ratio 9.88
Forward PE n/a
Dividend 13.50 (12.27%)
Ex-Dividend Date Aug 5, 2025
Volume n/a
Average Volume 11,449
Open n/a
Previous Close 110.00
Day's Range n/a
52-Week Range 46.12 - 110.00
Beta -0.11
RSI 100.00
Earnings Date Aug 8, 2025

About UGSE:QCIL

Quality Chemical Industries Limited manufactures and sells pharmaceutical drugs in Uganda. The company offers lamivudine/tenofovir disoproxil fumarate, dolutegravir, efavirenz, and zidovudine tablets for the treatment of HIV infection. It also provides lumartem/lumet tablets for the treatment of malaria; texavir and zentair for the treatment of Hepatitis B; and isoniazid/pyridoxine hydrochloride /sulfamethoxazole trimethoprim tablets for the treatment of tuberculosis. In addition, the company offers emeset for the treatment of nausea and vomiti... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 362
Stock Exchange Uganda Securities Exchange
Ticker Symbol QCIL
Full Company Profile

Financial Performance

In 2024, UGSE:QCIL's revenue was 267.13 billion, an increase of 0.67% compared to the previous year's 265.34 billion. Earnings were 40.65 billion, an increase of 28.00%.

Financial Statements

News

There is no news available yet.